Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ford, P. M.
Right arrow Articles by Ford, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ford, P. M.
Right arrow Articles by Ford, S. E.

Stroke, Vol 21, 66-71, Copyright © 1990 by American Heart Association


ARTICLES

Premature stroke in a family with lupus anticoagulant and antiphospholipid antibodies

PM Ford, D Brunet, DP Lillicrap and SE Ford
Department of Medicine, Queen's University, Kingston, Ontario, Canada.

Lupus anticoagulant and antiphospholipid antibodies are associated with thromboembolic phenomena in individuals both with and without systemic lupus erythematosus. A 32-year-old woman (the index case) with lupus anticoagulant, multiple cerebrovascular events, and a family history of premature stroke raised the possibility of a familial diathesis. Histories or interviews, examinations, and blood tests were obtained for 23 members of four generations of her family. Four individuals had suffered strokes and three more had suffered neurologic symptoms. Two living individuals who had suffered strokes, two individuals with neurologic symptoms, and five asymptomatic individuals had antiphospholipid activity in their blood. In addition, a cousin of the index case was found to have systemic lupus erythematosus and antiphospholipid activity. Elevated concentrations of von Willebrand factor antigen were found associated with some positive lupus anticoagulant assays, the highest concentrations in the two individuals with stroke. The characteristic presentation of the index case and her good response to treatment suggests that further studies of families in whom antiphospholipid antibodies may represent a risk factor for stroke is worthwhile.


This article has been cited by other articles:


Home page
LupusHome page
A. Sestak and K. O'Neil
Review: Familial lupus and antiphospholipid syndrome
Lupus, August 1, 2007; 16(8): 556 - 563.
[Abstract] [PDF]


Home page
LupusHome page
M Weber, G Hayem, M DeBandt, E Palazzo, S Roux, M-F Kahn, and O Meyer
The family history of patients with primary or secondary antiphospholipid syndrome (APS)
Lupus, May 1, 2000; 9(4): 258 - 263.
[Abstract] [PDF]


Home page
LupusHome page
W. Wilson
Review : Histocompatibility genes in antiphospholipid antibody syndrome
Lupus, August 1, 1996; 5(4): 259 - 262.
[PDF]


Home page
LupusHome page
G. Rivier, M. T. Herranz, M. A. Khamashta, and G. R.V. Hughes
Thrombosis and Antiphospholipid Syndrome: a Preliminary Assessment of Three Antithrombotic Treatments
Lupus, April 1, 1994; 3(2): 85 - 90.
[Abstract] [PDF]